Publication:
Pectin-hydroxypropylmethylcellulose drug delivery system for colon targeting - Design and in vitro evaluation

dc.contributor.authorsTurkoglu, M; Takka, S; Baran, H; Sakr, A
dc.date.accessioned2022-03-12T17:00:24Z
dc.date.accessioned2026-01-11T17:52:02Z
dc.date.available2022-03-12T17:00:24Z
dc.date.issued1999
dc.description.abstractPectin-Hydroxypropylmethylcellulose (HPMC) matrix tablets were prepared and evaluated of their dissolution/erosion properties to assess their colon targeting:possibility based on a gastrointestinal transit time concept. Dosage forms were tested in water and also separately in 0.1 N HCl and pH 6.8 buffer systems. HPMCs of three different molecular weights were incorporated as 25% into a pectin USP matrix in addition to pure pectin tablets. The effect of a pectin-degrading enzyme (Pectinex 3XL) on dissolution rate was also studied. It was found that dissolution/erosion rates were faster in water than in buffer solutions. The t(50) Values were 3, 3.4, 5.0, and 6.0 h in water and 4.6, 5.3, 9.7, and 11.7 h in a buffer system dependent on the viscosity grade of HPMC. Addition of 25% HPMC improved the mechanical properties of pectin matrix. Pectinex 3XL accelerated the degradation of pectin tablets as well as HPMC content of matrix. Pectin-HPMC system is recommended as protective wall layers to protect and carry protein drugs to the colon for targeting.
dc.identifier.doidoiWOS:000081848900004
dc.identifier.issn0031-711X
dc.identifier.urihttps://hdl.handle.net/11424/227300
dc.identifier.wosWOS:000081848900004
dc.language.isoeng
dc.publisherECV-EDITIO CANTOR VERLAG MEDIZIN NATURWISSENSCHAFTEN
dc.relation.ispartofPHARMAZEUTISCHE INDUSTRIE
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectcolon targeting
dc.subjectdrug targeting
dc.subjecthydroxypropylmethylcellulose
dc.subjectpectin
dc.subjectpectinase
dc.subjecttablets, dissolution, erosion
dc.subjectCALCIUM PECTINATE
dc.subjectFORMULATIONS
dc.titlePectin-hydroxypropylmethylcellulose drug delivery system for colon targeting - Design and in vitro evaluation
dc.typearticle
dspace.entity.typePublication
oaire.citation.endPage665
oaire.citation.issue7
oaire.citation.startPage662
oaire.citation.titlePHARMAZEUTISCHE INDUSTRIE
oaire.citation.volume61

Files